These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20338599)

  • 41. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases.
    Gurbuz AS; Gode F; Ozcimen N; Isik AZ
    Reprod Biomed Online; 2014 Nov; 29(5):541-4. PubMed ID: 25246114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study.
    Nouri K; Ott J; Lenart C; Walch K; Promberger R; Tempfer CB
    Gynecol Obstet Invest; 2016; 81(6):504-511. PubMed ID: 27399220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ovarian hyperstimulation syndrome: pathophysiology, risk factors, prevention, diagnosis and treatment].
    Lamazou F; Legouez A; Letouzey V; Grynberg M; Deffieux X; Trichot C; Fernandez H; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 2011 Nov; 40(7):593-611. PubMed ID: 21835557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ovarian hyperstimulation syndrome].
    Fukuda J; Shimizu Y; Tanaka T
    Nihon Rinsho; 2006 Jun; Suppl 2():434-7. PubMed ID: 16817436
    [No Abstract]   [Full Text] [Related]  

  • 45. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of spontaneous ovarian hyperstimulation syndrome with a potential mutation in the hCG/LH receptor gene.
    Akerman FM; Lei Z; Rao CV; Nakajima ST
    Fertil Steril; 2000 Aug; 74(2):403-4. PubMed ID: 10927070
    [No Abstract]   [Full Text] [Related]  

  • 47. [Incidence of ovarian hyperstimulation syndrome in in-vitro-fertilization treatment over a period of 11 years].
    Niederberger V; Rottensteiner-Grohsmann C; Turnheim K; Obruca A; Brunner M; Feichtinger W
    Wien Med Wochenschr; 1995; 145(23):642-5. PubMed ID: 8578756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester.
    Wiser A; Levron J; Kreizer D; Achiron R; Shrim A; Schiff E; Dor J; Shulman A
    Hum Reprod; 2005 Apr; 20(4):910-4. PubMed ID: 15618246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian hyperstimulation syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S188-93. PubMed ID: 19007627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperreactio luteinalis, presented as an acute abdomen.
    Morken NH; Friberg-Otterstad UM; Kahn JA
    Acta Obstet Gynecol Scand; 2007; 86(1):104-6. PubMed ID: 17230299
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Singleton pregnancies are as affected by ovarian hyperstimulation syndrome as twin pregnancies.
    De Neubourg D; Mangelschots K; Van Royen E; Vercruyssen M; Gerris J
    Fertil Steril; 2004 Dec; 82(6):1691-3. PubMed ID: 15589884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.
    Selman H; Brusco GF; Fiorini F; Barnocchi N; Mariani M; El-Danasouri I
    Fertil Steril; 2009 Apr; 91(4 Suppl):1611-3. PubMed ID: 19200960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M; Son WY; Buckett W; Tulandi T; Holzer H
    Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of hCG in reproductive medicine.
    Keay SD; Vatish M; Karteris E; Hillhouse EW; Randeva HS
    BJOG; 2004 Nov; 111(11):1218-28. PubMed ID: 15521866
    [No Abstract]   [Full Text] [Related]  

  • 56. Ovarian hyperstimulation syndrome.
    Avecillas JF; Falcone T; Arroliga AC
    Crit Care Clin; 2004 Oct; 20(4):679-95, ix. PubMed ID: 15388196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The ovarian hyperstimulation syndrome. Institutional experience].
    Serviere Zaragoza C; Camarero García A; Carranza Lira S; Kably Ambe A
    Ginecol Obstet Mex; 1994 Oct; 62():292-5. PubMed ID: 7995541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ovarian hyperstimulation syndrome].
    Inki P; Anttila L
    Duodecim; 1997; 113(4):301-7. PubMed ID: 11370099
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe OHSS: patients should be allowed to weigh the morbidity of OHSS against the benefits of parenthood.
    Mathur RS; Jenkins JM
    Hum Reprod; 1999 Sep; 14(9):2183-5. PubMed ID: 10469677
    [No Abstract]   [Full Text] [Related]  

  • 60. Ovarian hyperstimulation syndrome: diagnosis, prevention and management.
    Fawzy M; Harrison RF; Walshe J
    Ir Med J; 1998; 91(3):86-7. PubMed ID: 9695426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.